Company / Gross Profit per Share
BioNexus Gene Lab Corp Gross Profit per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit per Share
$0.60
FY2025
5-year range
$0.01 / $0.60
FY2021-FY2025
Trend
+727.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Gross Profit per Share changed +728% YoY in FY2025, a notable deviation from the 6-year average annual change of +654%.
Based on SEC 10-K filings.
0.60 in FY2025 with a 5-year CAGR of +104.9%.
Improved from $0.09 to $0.60 over the past 2 years.
Gross Profit per Share over time
Growth rates
- 3-Year CAGR
- +334.7%
- 5-Year CAGR
- +104.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, gross profit per share increased 727.5% year-over-year.
- Lowest gross profit per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 5.27 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross Profit per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.60 | +727.5% |
| FY2024 | $0.07 | -20.5% |
| FY2023 | $0.09 | +1148.9% |
| FY2022 | $0.01 | -44.5% |
| FY2021 | $0.01 | -20.9% |
| FY2020 | $0.02 | +2135.4% |
| FY2019 | $0.00 | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026